GH Research director granted 2,303 share options

A GH Research PLC director received 2,303 fully vested but delayed-exercisable share options with a long-dated expiry.

Rhea-AI Filing Summary

GH Research PLC (GHRS) reported that director Florian Schonharting2,303 share options$0.025 per Ordinary Share, are immediately fully vested, but are not exercisable until September 8, 2028, and expire on September 8, 2033. Following this award, he holds 2,303 share options directly.

Insider Trade Summary

Grant/Award: 2,303 shares

Grant/Award 1 txn

Insider Schonharting Florian

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Options (Right to Buy) F1	2,303	$0.00	$0.00

Holdings After Transaction: Share Options (Right to Buy) — 2,303 contracts (Direct)

Footnotes (1)

1. F1. The share options are immediately fully vested, but are not exercisable until September 8, 2028.

Key Figures

Share options granted: 2,303 options Exercise price: $0.025 per share Underlying Ordinary Shares: 2,303 shares +3 more

6 metrics

Share options granted 2,303 options Grant to director on September 8, 2026

Exercise price $0.025 per share Exercise price of granted share options

Underlying Ordinary Shares 2,303 shares Ordinary Shares underlying the granted options

Post-transaction option holdings 2,303 options Director’s direct derivative holdings after the grant

Option exercisability date September 8, 2028 Date from which options become exercisable

Option expiration date September 8, 2033 Expiration of granted share options

Key Terms

Share Options (Right to Buy), Ordinary Shares, exercise price, vested

4 terms

Share Options (Right to Buy) financial

"security titled “Share Options (Right to Buy)” was granted to the director"

Ordinary Shares financial

"underlying security title is stated as Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"options have an exercise price of $0.025 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vested financial

"The share options are immediately fully vested, but are not exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GHRS disclose for Florian Schonharting?

GH Research PLC disclosed that director Florian Schonharting2,303 share options on September 8, 2026, giving him the right to buy the company’s Ordinary Shares under specified terms.

What is the exercise price of the new GHRS share options?

The granted share options have an exercise price of $0.025 per Ordinary Share, meaning each option allows purchase of one Ordinary Share at that price when exercisable.

When can the newly granted GHRS options be exercised?

Although the 2,303 share options are immediately fully vested, they are not exercisable until September 8, 2028, according to the disclosure footnote.

When do Florian Schonharting’s new GHRS options expire?

The newly granted share options to director Florian Schonharting expire on September 8, 2033, providing a five-year window from the first exercisable date to exercise the options.

How many GHRS share options does Florian Schonharting hold after this grant?

After this grant, director Florian Schonharting holds 2,303 share options directly, as reported in the post-transaction holdings field for the derivative security.

Were the GHRS option grants made under a Rule 10b5-1 trading plan?

No. The disclosure indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 04:03 PM EDT Accepted by SEC EDGAR 09/09/2026 - 04:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schonharting Florian

(Last) (First) (Middle)

C/O GH RESEARCH PLC

JOSHUA DAWSON HOUSE, DAWSON STREET

(Street)

DUBLIN D02 RY95

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
GH Research PLC [ GHRS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Options (Right to Buy)	$0.025	09/08/2026		A		2,303		(1)	09/08/2033	Ordinary Shares	2,303	$0	2,303	D

Explanation of Responses:

1. The share options are immediately fully vested, but are not exercisable until September 8, 2028.

	/s/ Florian Schonharting	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)